Presenilin 1 protein directly interacts with Bcl-2

被引:59
作者
Alberici, A
Moratto, D
Benussi, L
Gasparini, L
Ghidoni, R
Gatta, LB
Finazzi, D
Frison, GB
Trabucchi, M
Growdon, JH
Nitsch, RM
Binetti, G
机构
[1] Ist Ricovero & Cura Carattere Sci, Ctr S Giovanni Dio, Neurobiol Lab, Alzheimers Dis Unit, I-25123 Brescia, Italy
[2] Univ Brescia, Sch Med, Inst Chem, I-25123 Brescia, Italy
[3] Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, I-00154 Rome, Italy
[4] Univ Zurich, Dept Psychiat Res, CH-8091 Zurich, Switzerland
[5] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02114 USA
关键词
D O I
10.1074/jbc.274.43.30764
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Presenilin proteins are involved in familial Alzheimer's disease, a neurodegenerative disorder characterized by massive death of neurons. We describe a direct interaction between presenilin 1 (PS1) and Bcl-2, a key factor in the regulation of apoptosis, by yeast two-hybrid interaction system, by co-immunoprecipitation, and by cross-linking experiments. Our data show that PS1 and Bcl-2 assemble into a macromolecular complex, and that they are released from this complex in response to an apoptotic: stimulus induced by staurosporine. The results support the idea of cross-talk between these two proteins during apoptosis.
引用
收藏
页码:30764 / 30769
页数:6
相关论文
共 51 条
[31]   Inhibition of presenilin 1 expression is promoted by p53 and p21WAF-1 and results in apoptosis and tumor suppression [J].
Roperch, JP ;
Alvaro, V ;
Prieur, S ;
Tuynder, M ;
Nemani, M ;
Lethrosne, F ;
Piouffre, L ;
Gendron, MC ;
Israeli, D ;
Dausset, J ;
Oren, M ;
Amson, R ;
Telerman, A .
NATURE MEDICINE, 1998, 4 (07) :835-838
[32]   Channel formation by antiapoptotic protein Bcl-2 [J].
Schendel, SL ;
Xie, ZH ;
Montal, MO ;
Matsuyama, S ;
Montal, M ;
Reed, JC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (10) :5113-5118
[33]   Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease [J].
Scheuner, D ;
Eckman, C ;
Jensen, M ;
Song, X ;
Citron, M ;
Suzuki, N ;
Bird, TD ;
Hardy, J ;
Hutton, M ;
Kukull, W ;
Larson, E ;
LevyLahad, E ;
Viitanen, M ;
Peskind, E ;
Poorkaj, P ;
Schellenberg, G ;
Tanzi, R ;
Wasco, W ;
Lannfelt, L ;
Selkoe, D ;
Younkin, S .
NATURE MEDICINE, 1996, 2 (08) :864-870
[34]   Interactions of the chaperone Hsp104 with yeast Sup35 and mammalian PrP [J].
Schirmer, EC ;
Lindquist, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (25) :13932-13937
[35]   CLONING OF A GENE BEARING MISSENSE MUTATIONS IN EARLY-ONSET FAMILIAL ALZHEIMERS-DISEASE [J].
SHERRINGTON, R ;
ROGAEV, EI ;
LIANG, Y ;
ROGAEVA, EA ;
LEVESQUE, G ;
IKEDA, M ;
CHI, H ;
LIN, C ;
LI, G ;
HOLMAN, K ;
TSUDA, T ;
MAR, L ;
FONCIN, JF ;
BRUNI, AC ;
MONTESI, MP ;
SORBI, S ;
RAINERO, I ;
PINESSI, L ;
NEE, L ;
CHUMAKOV, I ;
POLLEN, D ;
BROOKES, A ;
SANSEAU, P ;
POLINSKY, RJ ;
WASCO, W ;
DASILVA, HAR ;
HAINES, JL ;
PERICAKVANCE, MA ;
TANZI, RE ;
ROSES, AD ;
FRASER, PE ;
ROMMENS, JM ;
STGEORGEHYSLOP, PH .
NATURE, 1995, 375 (6534) :754-760
[36]   Suppression of signalling through transcription factor NF-AT by interactions between calcineurin and Bcl-2 [J].
Shibasaki, F ;
Kondo, E ;
Akagi, T ;
McKeon, F .
NATURE, 1997, 386 (6626) :728-731
[37]  
Shinozaki K, 1998, INT J MOL MED, V1, P797
[38]   Death-effector filaments: Novel cytoplasmic structures that recruit caspases and trigger apoptosis [J].
Siegel, RM ;
Martin, DA ;
Zheng, LX ;
Ng, SY ;
Bertin, J ;
Cohen, J ;
Lenardo, MJ .
JOURNAL OF CELL BIOLOGY, 1998, 141 (05) :1243-1253
[39]   Presenilin 1 associates with glycogen synthase kinase-3β and its substrate tau [J].
Takashima, A ;
Murayama, M ;
Murayama, O ;
Kohno, T ;
Honda, T ;
Yasutake, K ;
Nihonmatsu, N ;
Mercken, M ;
Yamaguchi, H ;
Sugihara, S ;
Wolozin, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (16) :9637-9641
[40]   Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo [J].
Thinakaran, G ;
Borchelt, DR ;
Lee, MK ;
Slunt, HH ;
Spitzer, L ;
Kim, G ;
Ratovitsky, T ;
Davenport, F ;
Nordstedt, C ;
Seeger, M ;
Hardy, J ;
Levey, AI ;
Gandy, SE ;
Jenkins, NA ;
Copeland, NG ;
Price, DL ;
Sisodia, SS .
NEURON, 1996, 17 (01) :181-190